Riskpilot← Back to searchSign inGet full accessKI-TERAPI SKOLEN AS
ASActiveOrg 875930842Storgata 108A, 2390 MoelvOther education n.e.c. · NACE 8559Est. 19950 employees
Revenue 2024
NOK 156K
+52% vs 2023
EBITDA margin
20.4%
+95% vs 2023
Equity ratio
54.6%
Financial strength
Net profit 2024
NOK 25K
+99% vs 2023
| Revenue | NOK 156K | +52% |
| EBITDA | NOK 32K | +95% |
| Net profit | NOK 25K | +99% |
| Total assets | NOK 572K | +14% |
| Equity | NOK 312K | +9% |
| Employees | 0 | — |
Legal name
KI-TERAPI SKOLEN AS
Org number
875930842
Legal form
Aksjeselskap
NACE code
8559 · Other education n.e.c.
Founded
16. november 1995
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Drive skole og utdanningsvirksomhet sammen med agentur- og handelsvirksomhet av enhver art samt virksomhet forbundet med dette.
Address
Storgata 108A, 2390 Moelv
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 231 | 235 | 233 | 103 | 156 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 88 | 62 | 71 | 16 | 32 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 88 | 62 | 71 | 16 | 32 |
| Net financials | −1 | −0 | 0 | −0 | 0 |
| Profit before tax | 87 | 62 | 71 | 16 | 32 |
| Tax | 19 | 14 | 16 | 4 | 7 |
| Net profit | 67 | 48 | 55 | 13 | 25 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 331 | 374 | 444 | 500 | 572 |
| Equity | 171 | 219 | 274 | 287 | 312 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 160 | 155 | 170 | 213 | 260 |
| Total debt | 160 | 155 | 170 | 213 | 260 |
EBITDA margin
20.4%
This company
15.8%
Market median
+29% vs market
20202024
Equity ratio
54.6%
This company
38.2%
Market median
+43% vs market
20202024
Return on equity
8.0%
This company
18.4%
Market median
-57% vs market
20202024
Net profit margin
16.0%
This company
8.1%
Market median
+98% vs market
20202024
Asset turnover
0.27×
This company
1.12×
Market median
-76% vs market
20202024
Debt / equity
0.83×
This company
0.62×
Market median
+34% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
GM Chief Executive Officer | Chief Executive Officer | 2014 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Herba Plus As
KI-TERAPI SKOLEN AS Board members of KI-TERAPI SKOLEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Geir Magne Andersen | Chief Executive Officer | 0 companies |
| Rolf André Andersen | Chairman | 0 companies |
| Inger Tyse | Board of Directors | 0 companies |